secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001493152-22-011719
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical appoints Scott C. Neils as CFO effective June 1, 2022
-------------------------------------------------------------------

- Annual base salary of $400,000; target bonus 50% of base, prorated for 2022.
- Severance provides 12 months base salary + prorated bonus + 12 months COBRA if terminated without cause.
- Double-trigger change-in-control severance: lump-sum payment of 12 months base salary.
- Employment agreement includes 12-month non-compete and non-solicitation covenants.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222011719/0001493152-22-011719-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315222011719/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-011719

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer